Genal

Oxyphenbutazone
Clinical data

AHFS/Drugs.com	International Drug Names
ATC code	M01AA03 (WHO) M02AA04 (WHO) S01BC02 (WHO)
Legal status
Legal status	AU: Withdrawn UK: Withdrawn US: Withdrawn
Identifiers
IUPAC name (RS)-4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione
CAS Number	129-20-4^Y
PubChem CID	104811
DrugBank	DB03585^Y
ChemSpider	94610^Y
UNII	A7D84513GV
KEGG	D08324^Y
ChEBI	CHEBI:76258^N
ChEMBL	CHEMBL1228^N
ECHA InfoCard	100.004.489
Chemical and physical data
Formula	C₁₉H₂₀N₂O₃
Molar mass	324.379 g/mol
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES O=C2N(c1ccc(O)cc1)N(C(=O)C2CCCC)c3ccccc3.O
InChI InChI=1S/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2^Y Key:CNDQSXOVEQXJOE-UHFFFAOYSA-N^Y
^NY (what is this?)

Oxyphenbutazone is a nonsteroidal anti-inflammatory drug (NSAID). It is a metabolite of phenylbutazone.

It was withdrawn from markets worldwide in mid-1980s due to bone marrow suppression and Stevens–Johnson syndrome.